ICU Medical (NASDAQ:ICUI) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Friday, BidAskClub reports.
A number of other analysts have also weighed in on ICUI. TheStreet upgraded ICU Medical from a “c+” rating to a “b” rating in a research note on Friday, May 10th. Zacks Investment Research lowered ICU Medical from a “buy” rating to a “hold” rating in a research note on Thursday, July 25th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $290.50.
ICUI stock traded up $0.74 during midday trading on Friday, reaching $255.95. The company’s stock had a trading volume of 116,053 shares, compared to its average volume of 110,052. The company’s fifty day moving average price is $249.45. ICU Medical has a 1 year low of $210.94 and a 1 year high of $321.70. The stock has a market cap of $5.26 billion, a price-to-earnings ratio of 33.20 and a beta of 0.81.
ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.96 by $0.39. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The business had revenue of $330.93 million for the quarter, compared to analyst estimates of $318.97 million. During the same quarter last year, the firm posted $2.26 earnings per share. The business’s revenue was down 11.0% compared to the same quarter last year. As a group, sell-side analysts expect that ICU Medical will post 8.55 EPS for the current year.
In other news, Director Robert S. Swinney sold 239 shares of the stock in a transaction on Monday, July 15th. The stock was sold at an average price of $248.73, for a total transaction of $59,446.47. Following the transaction, the director now owns 19,662 shares of the company’s stock, valued at approximately $4,890,529.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Kevin J. Mcgrody sold 7,344 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $231.68, for a total value of $1,701,457.92. Following the transaction, the insider now directly owns 7,574 shares in the company, valued at approximately $1,754,744.32. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,931 shares of company stock worth $9,228,056. Insiders own 11.40% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of ICUI. FMR LLC grew its position in shares of ICU Medical by 91.1% during the 4th quarter. FMR LLC now owns 417,787 shares of the medical instruments supplier’s stock worth $95,937,000 after buying an additional 199,185 shares in the last quarter. Norges Bank bought a new position in shares of ICU Medical during the 4th quarter worth $41,575,000. Janus Henderson Group PLC grew its position in shares of ICU Medical by 5.2% during the 2nd quarter. Janus Henderson Group PLC now owns 2,825,836 shares of the medical instruments supplier’s stock worth $711,856,000 after buying an additional 140,123 shares in the last quarter. Lazard Asset Management LLC bought a new position in shares of ICU Medical during the 1st quarter worth $19,481,000. Finally, Rice Hall James & Associates LLC bought a new position in shares of ICU Medical during the 2nd quarter worth $18,243,000. 90.14% of the stock is currently owned by institutional investors and hedge funds.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: Cost of Goods Sold (COGS)
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.